Cargando…

Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer

Enhancer RNA (eRNA) is a type of noncoding RNA transcribed from the enhancer. Although critical roles of eRNA in gene transcription control have been increasingly realized, the systemic landscape and potential function of eRNAs in cancer remains largely unexplored. Here, we report the integration of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhao, Lee, Joo-Hyung, Ruan, Hang, Ye, Youqiong, Krakowiak, Joanna, Hu, Qingsong, Xiang, Yu, Gong, Jing, Zhou, Bingying, Wang, Li, Lin, Chunru, Diao, Lixia, Mills, Gordon B., Li, Wenbo, Han, Leng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783481/ https://www.ncbi.nlm.nih.gov/pubmed/31594934 http://dx.doi.org/10.1038/s41467-019-12543-5

Ejemplares similares

The genetic and pharmacogenomic landscape of snoRNAs in human cancer
por: Liu, Yaoming, et al.
Publicado: (2020)

Comprehensive characterization of circular RNAs in ~ 1000 human cancer cell lines
por: Ruan, Hang, et al.
Publicado: (2019)

Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors
por: Zhang, Zhao, et al.
Publicado: (2020)

Exploring the potential of eRNAs in cancer immunotherapy
por: Luo, Lianxiang, et al.
Publicado: (2022)

eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer
por: Zhang, Xiaona, et al.
Publicado: (2020)

Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades
por: Napoli, Sara, et al.
Publicado: (2022)

Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease Treatment
por: Ding, Mengting, et al.
Publicado: (2018)

Profiling of immune features to predict immunotherapy efficacy
por: Ye, Youqiong, et al.
Publicado: (2021)

Sex-associated molecular differences for cancer immunotherapy
por: Ye, Youqiong, et al.
Publicado: (2020)

eRNA profiling uncovers the enhancer landscape of oesophageal adenocarcinoma and reveals new deregulated pathways
por: Ahmed, Ibrahim, et al.
Publicado: (2023)

HeRA: an atlas of enhancer RNAs across human tissues
por: Zhang, Zhao, et al.
Publicado: (2020)

GPEdit: the genetic and pharmacogenomic landscape of A-to-I RNA editing in cancers
por: Ruan, Hang, et al.
Publicado: (2021)

Potential mechanisms and prognostic model of eRNAs-regulated genes in stomach adenocarcinoma
por: Gao, Liuying, et al.
Publicado: (2022)

Global analysis of tRNA and translation factor expression reveals a dynamic landscape of translational regulation in human cancers
por: Zhang, Zhao, et al.
Publicado: (2018)

Single-cell reconstruction of differentiation trajectory reveals a critical role of ETS1 in human cardiac lineage commitment
por: Ruan, Hang, et al.
Publicado: (2019)

A Robust Prognostic Gene Signature Based on eRNAs-Driven Genes in Prostate Cancer
por: Fan, Shuaishuai, et al.
Publicado: (2021)

The integrated landscape of eRNA in gastric cancer reveals distinct immune subtypes with prognostic and therapeutic relevance
por: Hu, Xin, et al.
Publicado: (2022)

Comprehensive transcriptomic analysis of immune-related eRNAs associated with prognosis and immune microenvironment in melanoma
por: Gan, Yuling, et al.
Publicado: (2022)

Identification of Key eRNAs for Spinal Cord Injury by Integrated Multinomial Bioinformatics Analysis
por: Huang, Runzhi, et al.
Publicado: (2021)

Enhancer RNA (eRNA) in Human Diseases
por: Wang, Yunzhe, et al.
Publicado: (2022)

Reprogramming Transcription via Distinct Classes of Enhancers Functionally Defined by eRNA
por: Wang, Dong, et al.
Publicado: (2011)

DeepITEH: a deep learning framework for identifying tissue-specific eRNAs from the human genome
por: Zhang, Tianjiao, et al.
Publicado: (2023)

Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer
por: Zhao, Jingwen, et al.
Publicado: (2016)

Festschrift für Erna Lesky zum 70. Geburtstag
por: Jarcho, Saul
Publicado: (1982)

APAatlas: decoding alternative polyadenylation across human tissues
por: Hong, Wei, et al.
Publicado: (2020)

Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects
por: Wan, Lilin, et al.
Publicado: (2022)

eRNAs Identify Immune Microenvironment Patterns and Provide a Novel Prognostic Tool in Acute Myeloid Leukemia
por: Jiang, Ziming, et al.
Publicado: (2022)

Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype
por: Qin, Na, et al.
Publicado: (2020)

Revealing eRNA interactions: TF dependency and convergent cooperativity
por: Lee, Seungha Alisa, et al.
Publicado: (2023)

Characterization of influenza A virus induced transposons reveals a subgroup of transposons likely possessing the regulatory role as eRNAs
por: Shen, Steven S., et al.
Publicado: (2022)

LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy
por: Egranov, Sergey D., et al.
Publicado: (2020)

The degree of enhancer or promoter activity is reflected by the levels and directionality of eRNA transcription
por: Mikhaylichenko, Olga, et al.
Publicado: (2018)

Systematic functional characterization of antisense eRNA of protocadherin α composite enhancer
por: Zhou, Yuxiao, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

eRNA co-expression network uncovers TF dependency and convergent cooperativity
por: Lee, Seungha Alisa, et al.
Publicado: (2023)

A genome–wide CRISPR activation screen identifies SCREEM a novel SNAI1 super-enhancer demarcated by eRNAs
por: Uthaya Kumar, Dinesh Babu, et al.
Publicado: (2023)

The rhizobial type III effector ErnA confers the ability to form nodules in legumes
por: Teulet, Albin, et al.
Publicado: (2019)

Population-scale study of eRNA transcription reveals bipartite functional enhancer architecture
por: Kristjánsdóttir, Katla, et al.
Publicado: (2020)

Identification of prognostic and immunotherapy-related eRNA ID2-AS1 in bladder cancer
por: Zhang, Lei, et al.
Publicado: (2022)

Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
por: Jing, Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_efrqskhk20m74a4mlbbo2jpk1r